JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRAYER, O.
Right arrow Articles by MEILMAN, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRAYER, O.
Right arrow Articles by MEILMAN, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 113, Issue 4, 446-459, 1955
Copyright © 1955 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON VERATRUM ALKALOIDS. XXI. THE ACTION OF VERATRAMINE UPON IMPULSE GENERATION IN THE DOG HEART

OTTO KRAYER 1, R. B. ARORA 1, and EDWARD MEILMAN 1

1 Department of Pharmacology, Harvard Medical School, Boston

The heart rate in the presence of S-A rhythm in the heart-lung preparation of the dog, as well as in the heart in situ, is reduced by veratramine. This negative chronotropic action of veratramine is not abolished or prevented by atropine.

The heart rate in the presence of A-V rhythm in the anesthetized dog is influenced by veratramine in qualitatively the same way as in the presence of S-A rhythm in the intact circulation and in the heart-lung preparation. After A-V rhythm has been established in the anesthetized dog by clamping off the S-A node, the heart rate is increased by the sympathomimetic amines l-epinephrine, l-norepinephrine, isopropylarterenol and tuaminoheptane. Veratramine antagonizes the positive chronotropic action of the sympathomimetic amines in the presence of A-V rhythm.

In the anesthetized dog in the presence of A-V rhythm, veratramine in a dose of 0.06 to 0.1 mgm./kgm. body weight is capable of producing asystole lasting for short periods, while, when the S-A node is the dominant pacemaker, asystole has not been observed under the same conditions and in this dosage range.

In the heart-lung preparation veratramine does not influence the increased heart rate resulting from spontaneous auricular fibrillation, or from the increased spontaneity of the ventricles in ventricular tachycardia caused by ouabain.

Veratramine, in doses which exert strong antiaccelerator action, or which cause a marked negative chronotropic effect in the presence of S-A rhythm, appears to possess little, if any, quinidine-like antiarrhythmic properties.

Submitted on December 22, 1954







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1955 by the American Society for Pharmacology and Experimental Therapeutics.